Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Berry Genomics, Prenetics Form Chinese DTC Joint Venture

    Diagnostics World Brief | Berry Genomics, China's leading clinical genomics testing company, and Prenetics Limited, the leading consumer digital health and genetics testing company in Southeast Asia and Europe, have formed a joint venture company that will deliver consumer digital health and genetics testing services in mainland China.

    Nov 8, 2018
  • The Lantern Project Looks To Shorten Diagnostic Odyssey For Rare Genetic Diseases

    Diagnostics World News | A new testing program created by Sanofi Genzyme and PerkinElmer looks to shorten the diagnostic odyssey for patients suffering from rare genetic diseases by providing confirmatory DNA testing and phlebotomy services to patients suffering from specific types of lysosomal storage disorders (LSDs).

    Nov 6, 2018
  • XtalPi, Qure.ai, Thermo Fisher Scientific, And More: News From October 2018

    Diagnostics World | October featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including XtalPi, Qure.ai, Thermo Fisher Scientific, and more.

    Oct 31, 2018
  • Improving the Clinical Utility of DTC Genetic Tests

    Diagnostics World News | An estimated 100 million-plus people, roughly one-third of the U.S. population, will have had their DNA analyzed using an at-home genetic test kit by 2021. Up to 60% of the time, identified genetic variants are going to be proven correct with retesting in a medical-grade laboratory. For an investment starting at under $100, individuals can learn things that might save their life—or cause them to have unneeded treatments and surgeries—without a physician’s order for the test and often without follow-up of any kind by a healthcare professional.

    Oct 29, 2018
  • Nature Study Brings New Hope For Drug Discovery In Schizophrenia, Other Diseases

    Diagnostics World News Brief | Scientists have released results from a proof-of-concept study demonstrating that patient-derived cells offer a more effective approach for assessing drug response than conventional methods.

    Oct 26, 2018
  • Mayo App Helps Consumers Interpret Genetic Test Results

    Diagnostics World News | Mayo Clinic teams up with Helix to raise the “genomic literacy” of consumers.

    Oct 25, 2018
  • Diagnosing Disease X

    Diagnostics World Contributed Commentary | Serving as a placeholder for a yet-to-be-identified potential disaster, Disease X represents emerging pathogens that present a significant health risk and potential for an international epidemic. An effective response to emerging and re-emerging pathogens – including Disease X – depends on a deep understanding of infectious diseases, backed by a global network of experts and governmental organizations committed to prompt and full cooperation.

    Oct 23, 2018
  • Does Self-Testing Hold The Key To Tackling The Rising Threat Of A Global STI Epidemic?

    Diagnostics World Contributed Commentary | Novel diagnostic solutions can play a central role in treating the growing sexual health epidemic.

    Oct 18, 2018
  • Chan And Zuckerberg Back Diagnosing Mystery Illnesses

    The Atlantic | Backed by major funders, a group of scientists has created a platform to help the world’s disease detectives.

    Oct 17, 2018
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56 (current)
  • 57
  • 58
  • 59
  • 60
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy